Scancell (LON:SCLP) Releases Earnings Results

Scancell (LON:SCLP) announced its quarterly earnings results on Thursday. The company reported GBX (1.35) (($0.02)) earnings per share (EPS) for the quarter, Digital Look Earnings reports.

Scancell Stock Up 3.4 %

Shares of LON SCLP traded up GBX 0.33 ($0.00) during mid-day trading on Thursday, hitting GBX 9.99 ($0.12). 2,913,912 shares of the stock traded hands, compared to its average volume of 1,505,725. The stock has a fifty day moving average price of GBX 11.02 and a 200-day moving average price of GBX 13.67. The company has a market cap of £92.87 million, a price-to-earnings ratio of -999.00 and a beta of 0.35. The company has a debt-to-equity ratio of 61.41, a quick ratio of 13.01 and a current ratio of 3.42. Scancell has a 52 week low of GBX 8.60 ($0.11) and a 52 week high of GBX 19.75 ($0.25).

About Scancell

Scancell (LSE:SCLP) is a clinical stage immunotherapy biotech company developing treatments for significant unmet needs in cancer. We aim to translate our innovation and creativity into increased and durable responses in patients without compromising safety, addressing hard-to-treat cancers.

Scancell has developed a pipeline of ‘off-the-shelf’ vaccines to induce immune responses and highly tumour specific monoclonal antibodies to redirect immune cells or drugs.